Dare Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Dare Bioscience, Inc. (DARE) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number of 412.47 thousand shares as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber · last filed 2019-11-12
- 2019-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 412.47K shares.
- 2019-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 427.70K shares.
- 2019-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 650.15K shares.
- 2018-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 535.03K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number as first filed |
|---|---|---|
| 2019-09-30 | 412.47K shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 427.70K shares 10-Q · filed 2019-08-14 | |
| 2019-03-31 | 650.15K shares 10-Q · filed 2019-05-14 | |
| 2018-09-30 | 535.03K shares 10-Q · filed 2018-11-13 | |
| 2018-06-30 | 529.72K shares 10-Q · filed 2018-08-13 | |
| 2018-03-31 | 526.34K shares 10-Q · filed 2018-05-14 | |
| 2017-12-31 | 526.34K shares 10-K · filed 2018-03-28 | |
| 2017-09-30 | 545.64K shares 10-Q · filed 2017-11-13 | |
| 2017-06-30 | 26.39K shares 8-K/A · filed 2017-10-02 | 220.50K shares 10-Q · filed 2017-08-14 |
| 2017-03-31 | 1.91M shares 10-Q · filed 2017-05-12 | |
| 2016-12-31 | 16.67K shares 8-K/A · filed 2017-10-02 | 1.63M shares 10-K · filed 2017-03-31 |
| 2016-09-30 | 1.45M shares 10-Q · filed 2016-11-03 | |
| 2016-06-30 | 1.39M shares 10-Q · filed 2016-08-04 | |
| 2016-03-31 | 1.16M shares 10-Q · filed 2016-05-02 | |
| 2015-12-31 | 1.00M shares 10-K · filed 2016-03-10 | |
| 2015-09-30 | 807.42K shares 10-Q · filed 2015-11-16 | |
| 2015-06-30 | 679.74K shares 10-Q · filed 2015-08-06 | |
| 2015-03-31 | 580.48K shares 10-Q · filed 2015-05-06 | |
| 2014-12-31 | 786.62K shares 10-K · filed 2015-03-19 | |
| 2014-09-30 | 736.02K shares 10-Q · filed 2014-11-13 | |
| 2014-06-30 | 655.95K shares 10-Q · filed 2014-08-12 | |
| 2014-03-31 | 637.17K shares 10-Q · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |